MedPath
FDA Approval

Epinephrine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
BPI LABS LLC
DUNS: 078627620
Effective Date
October 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Epinephrine(0.1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

BPI LABS LLC

BPI LABS LLC

078627620

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Epinephrine

Product Details

NDC Product Code
54288-155
Route of Administration
INTRAVENOUS, INTRACARDIAC
Effective Date
October 5, 2023
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8.6 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.5 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: YKH834O4BHClass: ACTIBQuantity: 0.1 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath